Poor
Poorly Aligned
Patient Risk:
Low
Summary
The AI-generated claims largely exceed or misinterpret the provided label content. The available label sections discuss intravenous magnesium sulfate use in pregnancy and related precautions, with no guidance on interactions with levothyroxine or timing/dosing recommendations for oral levothyroxine. Minimal alignment exists (e.g., general monitoring of magnesium levels).
Category Scores
MonitoringRecommendations
60
Accurate Statements
Providers may recommend lab checks.
Label indicates monitoring serum magnesium levels to avoid overdosage; monitoring is required.
Unsupported Statements
Magnesium supplements should not be taken at the same time as levothyroxine.
No guidance about levothyroxine interactions is present in the provided label sections.
Magnesium can bind to levothyroxine in the gut.
No information about levothyroxine-mg interactions is present in the label.
This binding reduces its absorption by up to 30% or more.
No data on absorption reduction due to magnesium interacting with levothyroxine in the label.
Reduced absorption may lower thyroid hormone levels.
Label does not address thyroid hormone levels or levothyroxine absorption.
Reduced absorption may worsen hypothyroidism symptoms.
Label does not discuss hypothyroid symptom changes related to levothyroxine interactions.
Separate doses by at least 4 hours.
No dosing timing guidance for levothyroxine interactions is provided in the label.
Levothyroxine is best absorbed on an empty stomach, taken first thing in the morning with water only.
No levothyroxine administration guidance is provided in the label.
Wait 30-60 minutes before food or other supplements after taking levothyroxine.
No levothyroxine timing guidance is provided in the label.
Then take magnesium later—ideally 4 hours after to minimize interference.
No levothyroxine-magnesium timing guidance is provided in the label.
Magnesium forms insoluble complexes with levothyroxine, preventing uptake in the intestines.
No such interaction data in the label.
This applies to magnesium oxide, citrate, glycinate, and other forms, plus magnesium in multivitamins or antacids.
No levothyroxine interaction specifics by magnesium form are in the label.
Calcium, iron, and aluminum follow similar rules.
No related interactions with levothyroxine described in the label.
Short-term: Reduced levothyroxine effectiveness, potentially causing fatigue, weight gain, or cold intolerance.
No such safety/effectiveness data in the label.
Long-term: Poorly controlled thyroid levels, requiring dose adjustments.
No such safety/effectiveness data in the label.
Monitor TSH levels via blood tests if interactions occur.
The label discusses monitoring magnesium levels, not TSH as related to interactions.
Topical magnesium (oils, lotions) bypasses gut absorption and poses low risk with levothyroxine.
Label does not address topical magnesium or levothyroxine interactions.
Food sources like nuts or spinach have minimal impact if spaced properly.
No guidance on dietary interactions with levothyroxine in the label.
Consult a doctor for personalized advice, especially with conditions like low magnesium levels.
Label provides generalized precautions but does not include this phrasing.
Always talk to your doctor before starting magnesium.
Label does not contain this advisory wording.
Thyroid patients often need magnesium for muscle cramps or sleep but must time it right.
No such guidance in the label.
Providers may switch to evening levothyroxine dosing.
No levothyroxine dosing timing guidance in the label.
Contradictions
Important Omissions
No label content addressing levothyroxine-magnesium interactions, timing, or specific drug interaction guidance.
Importance:
High
Safety Assessment
Potential Patient Risk:
Low
AI claims largely extrapolate beyond the label; incorrect interactions could mislead safety unless strictly confined to label-supported magnesium monitoring content.
Regulatory Assessment
| On Label |
No |
| Off-label Discussion |
Yes |
| Promotes Unapproved Use |
No |
| Hallucination Risk |
Low |
Recommendation
Poorly Aligned
Primary Issue
Major extrapolation beyond label content about levothyroxine–magnesium interactions.
Suggested Improvement
Limit statements to content actually in the label (magnesium monitoring; IV magnesium use in obstetrics). Avoid asserting interactions with levothyroxine or timing recommendations not present in the label; if interactions are relevant, cite official labeling or guidance and clearly distinguish between label-supported facts and extrapolations.